Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with mild cognitive impairment (MCI) or early Alzheimer's disease, confirmed by a specific brain scan showing signs of Alzheimer's-related changes in the brain.
- People of any gender (male or female).
- People aged between 50 and 85 years old.
- People who are not currently taking part in any other research studies.
- People who are willing and able to give written consent to participate in the study before it begins.
- People who are able to communicate clearly with the research team and follow the study procedures through to completion.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have another type of neurological (brain or nervous system) condition, such as vascular dementia, Lewy body dementia, frontotemporal dementia, or prion diseases.
- People who have certain whole-body illnesses or conditions affecting the body's chemical processes, such as an underactive thyroid, vitamin B12 deficiency, or liver or kidney failure.
- People who have certain infections affecting the brain or nervous system, such as neurosyphilis, HIV-related brain disease, or other similar infections.
- People whose memory or thinking problems are caused by a psychiatric condition, such as severe depression or schizophrenia.
- People who have long-term use of certain medications (such as benzodiazepines or anticholinergic drugs) or who have alcohol dependence, where these may be affecting brain function.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13958125492
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Aβ-PET centiloid values
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.